 SANTA CLARA, Calif., Oct. 05, 2021 GLOBE NEWSWIRE -- Shockwave Medical, Inc. Nasdaq: SWAV, a pioneer in the development and commercialization of Intravascular Lithotripsy IVL to treat complex calcified cardiovascular disease, today announced it will report financial results for the third quarter 2021 after market close on Monday, November 8, 2021. Company management will host a corresponding conference call beginning at 2:00 p.m. Pacific Time 5:00 p.m. Eastern Time. 